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Summary: A possible mode of action involving electron transfer is advanced for the 9-
anilinoacridines. The mechanism entails formation of toxic oxy radicals which destroy the 
neoplasm. Cyclic voltammetry was performed on iminium type ions derived by protona-
tion of the acridines. Reductions were generally reversible with potentials of about 
-0.60 V. Involvement of quinoidal metabolites is also a possibility. The relationship of 
electrochemical behavior to structure and physiological activity is addressed. 
Despite the fad that much insight has been 
gained in recent years concerning the action 
of physiologically important drugs, the inti-
mate pathways of operation are generally 
unknown. A mechanism which is gaining 
increased acceptance involves redox cycling 
of the active substance, accompanied by 
electron transfer (ET).· Recent reviews deal 
with this mode of action (Halliwell & Gutter-
idge 1985; Sies, 1985; Kappus, 1986). The 
comprehensive radical mechanism for anti-
cancer agents was first proposed more than 
two decades ago (Holman, 1956; Kovacic, 
1959), and has received increasing support, 
particularly in recent years (Oberley & 
Buettner, 1979; Kovacic, 1984; Lown, 1985; 
Kovacic et al., 1986). There are several 
categories of ET agents, including quinones, 
metal complexes, aromatic nitro com-
pounds, and iminium moieties. Of the 
~hrious groups, the iminium class has been 
e least investigated systematically. ~ecently the theory was advanced that the 
b~iniur:n ion 1 plays an important role in 
rologrcal functions (Kovacic, 1984). These 
sp . 
ecres are formed endogenously (Knabe, 
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1979; Overton ef a/., 1985). The chief func-
tion is thought to be participation in ET: 
beneficial transformations, interference with 
normal ET, or generation of toxic oxy 
radicals. Application of the general theme 
has been made to carcinogens (Kovacic et 
a/., I986a) (0-alkyl guanine salt in DNA), 
antibacterial agents (Ryan ef al., I 985; 
Crawford et al., 1986a; Ames et al., 1986d), 
CNS agents [benzodiazepines (Crawford et 
al., 1986b, 1-methyl-4-phenyl-1,2,3,6-tetra-
hydropyridine (Ames et al., 1986a), phen-
cyclidine (Ames et al., 1986b), nicotine 
(Ames et al., 1986b], spermine (Ames et al., 
1986b ), anti-malarial agents (Ames et a/., 
1985), mesoionic compounds (Ames et al., 
1986c), anti-cancer drugs (Kovacic et al., 
1986b; Crawford et al., 1987a; Crawford et 
al., 1987b), and amebicides (Ames et al., 
198 7). The natural phagocytic response to 
foreign bodies involves attack by activated 
oxygen (Baehner ef al., 1982). 
In relation to anti-neoplastic action, the 
mechanism in some cases presumably 
© The Macmillan Press Ltd, 1987 
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involves interaction of 1, usually conju-
gated, with a substrate, e.g., protein or 
DNA, entailing electron abstraction. Reduc-
tion of 1 should be energetically favorable 
due to its electrophilic nature (Kovacic, 
1984). Oxidation of the radical intermediate 
2 by electron donation to an acceptor, e.g., 
oxygen, resulting in superoxide formation, 
completes the ET process. Derived oxy 
species, such as the hydroxyl radical, then 
exert a ·lethal effect on the tumor cell by 
attacking vital cellular constituents. The 
well known paradox of oncology, that 
generally the substances which are anti-
neoplastic may also induce cancer, gives 
support to this mechanism of action, since 
oxy radicals have been implicated in carci-
nogenesis (Kovacic et al., 1986a, b). The 
ability to combat this condition may then be 
linked to the same property. Also many 
tumor cells are more susceptible than nor-
mal ones to elevated concentrations of oxy 
radicals. A more complete treatment of this 
subject is presented elsewhere (Kovacic et 
al., 1986b). 
9-Anilinoacridines (Baguley et al., 1981) 
elicit a wide range of biological responses 
including anti-tumor effects. The objective 
of the present study was to determine the 
electrochemical characteristics of iminium 
ions derived from these agents. The rela-
tionship of electrochemical behavior to 
structure and physiological activity is 
addressed. Alternate mechanistic pathways 
are considered. 
Materials and methods 
The eight 9-anilinoacridine compounds 
were supplied by the Drug Synthesis and 
Chemistry Branch, Division of Cancer 
Treatment, National Cancer Institute. The 
electrolyte used in the electrochemical stu-
dies was tetraethylammonium perchlorate 
(G. F. Smith Chemical Co.); dimethylform-
amide (DMF, Aldrich Chemical Co.) was 
obtained in the highest available purity; 
absolute ethanol (US Industrial Chemical 
Co.) was used to prepare the aqueous solu-
tions. The appropriate volume of stock solu-
tions of acetic acid and sodium hydroxide 
was added directly to the electrochemical 
cell. Acetic acid was used to mimic the weak 
acids found in vivo. Electrochemical solu-
tions were prepared by adding a weighed 
amount of the test compound and diluting 
to the desired concentration. 
Cyclic voltammetry data were recorded 
with a P ARC model 17 4A polarographic 
analyzer connected to a Hewlett Packard 
model 7035B X-Y recorder. Scan rates 
generally ranged from 20 to 200 mV s- 1• 
All solutions were saturated for 15 min with 
prepurified nitrogen which was passed 
through an oxygen scrubbing system. The 
electrode consisted of a hanging mercury 
drop (HMDE) working electrode, with a 
platinum wire as the counter. For each scan 
a new mercury drop was used. The refer-
ence was a saturated calomel electrode 
(SCE) (Corning). Observed potentials (our 
work and literature values) were converted 
to the normal hydrogen electrode (NHE) by 
addition of 0.24 V to the SCE values. The 
reported values are the average of two or 
more measurements involving fresh solu-
tions. The following equations were used 
for the half-wave potentials and the differ-
ences in potentials: 
E! =(fpc+ EP)/2 
L\ EP = I Epa - fpc I and 
. fpp/2 = I fpc - fpc/21 
Results and discussion 
Compound 3a (Figure 1) as the hydrochlor-
ide salt gave an E! of - 0 .60 V in DMF and 
a . .L\EP of 50 mV. The reduction was diffu-
Sion controlled as determined from the con-
stant current function (equation (1}, below) 
[data not shown] with an i fi value 
. 1 Pl' pc h 
approximate y equal to one (Table 1). T e 
free base exhibited irreversible reduction at 
-1.26 v. 
CF= i j V! X c p (1) 
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Table I Cyclic voltammetry of substituted acridines• 
Compound [HO-]mM [HOAc]mM -E i ip./ip< i\Er 
3a 0.60 0.93 50 
24 0.61 0.93 50 
0.5 1.26b 
0.5 24 0.78 1.0 70 
0.5 46 0.70 1.0 65 
0.5 66 0.67 0.96 60 
3bc 0.60 1.0 50 
0.5 1.29b 
0.5 24 0.74 1.0 60 
0.5 46 0.67 1.0 40 
0.5 66 0.64 0.92 60 
3c 0.59 0.97 60 
0.5 I.30b 
0.5 24 0.74 1.0 65 
0.5 46 0.68 0 .94 50 
0 .5 66 0.64 0.96 55 
3d 0.60 0.83 55 
1.0 I.30b 
1.0 24 0.73 0.94 70 
1.0 46 0.67 0.91 65 
1.0 66 0.64 0.88 60 
3ec 0 .59 0.96 65 
0.5 1.29b 
0.5 24 0.73 0.98 60 
0.5 46 0.67 0.84 50 
0 .5 66 0.63 0.81 50 
3£ d 
0 .5 0.61 0.81 90 
1.0 1.25b 
1.0 24 0.71 1.0 90 
1.0 46 0.66 0.82 85 
1.0 66 0.61 0.80 75 
3g 0 .40 1.0 50 
0.5 0.63·, 1.22b 
1.0 1.22b 
0.5 24 0 .69•, 0. 79. 
0.5 46 0 .61· 1.0 110 
0.5 66 0 .57 105 
3h 0 .59 0.82 55 
0.5 1.30b 
0.5 24 0.71 0.92 95 
0 .5 46 0 .67 0 .88 80 
0.5 66 0.63 0.88 70 
"100m V s - 1, tetraethylammonium perchlorate (0.1 M), substrate (0.5 mM, 
unless otherwise indicated), DMF, HMDE vs NHE, reversible 
blrreversible, ES value 
'Substrate, 0.2 mM 
dStrong adsorption on the electrode, adsorption EP about 
• See text for details 
-0.60V 
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- 0 16 - 0 .76 
E vs NHEIV 
Figure 1 Cyclic voltammogram of 3a in 
dimethylformamide, hanging mercury drop 
electrode, scan rate 100 mV s- 1 
The ratio of the currents was unity. The 
remaining acridines exhibited the same type 
of behavior with the exception of 3f and 
3g. Compound 3f (dihydrochloride) 
adsorbed strongly on the electrode. How-
ever, for the monohydrochloride, an £1 of 
-0.61 V was observed. The compound 
behaved similarly to the others under the 
various remaining conditions. Compound 
3g exhibited an £! of - 0.40 V as the acid 
salt. This value 1s due to the electron-
withdrawing effect of the carboxyl group. 
One equivalent of base produced a quasi-
reversible wave (il.E = 120 mV) with cur-
rent of about 40% of lhe original at an £1 of 
-0.63 V. The relatively positive potential 
is likely due to nuclear protonation by 
carboxyl. An irreversible peak at - 1.22 V 
was also observed. Addition of 1.0 mM base 
produced only a wave at EP- 1.22 V which 
arises from the unprotonated acridine ring. 
After addition of acetic acid (24 mM) to the 
free base, a very broad peak was obtained 
with an Efc at - 0. 79 V and a shoulder, 
EP"' - 0.6~ V. The broadness may be due 
to the superposition of two cathodic peaks, 
Formation of the cation by addition of 
acetic acid also produced more positive 
potentials (- 0.67 to - 0.78 V) with il.E 
ranging from 60 to 70 mV (Table 1), close t6 
the theoretical value of 59 mV for a one-
electron process (Bard & Faulkner, 1980). 
3 
NCS 
Compound number 
a 12056 
b 10666 
c 12516 
d 17280 
e 36126 
f 32941 
g 12509 
h 165714 
1 I 
fll2' Y3' 
NH 
Substitute 
2·0CH3; 6-CI; 1 I -OH·HCI 
2 
3 
2-0CH3; 6-CI; 1 '·OH; 2'-CH 2NEt2 ·2HCI 
2-0CH3; 6-CI; 1 ' ·OH; 2' -CH2N(CH2 )4 ·HCI 
2-0CH3; 6-CI; 1 ' -OH; 2'-CH 2N(CH2CH2Cih·2HCI 
2-0CHJ; 6-CI; 1 '-OH; 2'-CH 2N[(CH2hCH3h·2HCI 
3-CI; 5-CHJ; 1'-0H; 2'-CH2NEt2 ·2HCI 
2-0CH3; 6-CI; 1 '-COOH ; 2'-0H·HCI 
1 '-OEt·HCI 
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possibly from protonation of the nucleus by 
both carboxyl and added acid. Stronger 
concentrations produced a single peak 
(Table 1). The position and nature of the 
substituents on the acridine ring exert little 
effect on the reduction potential, cf., 3a vs 
3h (Table I). 
Cyclic voltammetry of 3a in 50% 
aqueous ethanol gave £! = - 0.66 V, with a 
~EP of 40 mV and iPafi c of 0.90 (data not 
shown). Addition of o.S mM base produced 
a complex wave with E = - 1.06 V and a 
shoulder around - o.92 V. Acetic acid 
(46 mM) resulted in a reversible peak with 
an £! of - 0.66 V. Due to the similarity of 
results to those in DMF, the remaining 9-
anilino derivatives were not studied under 
these conditions. 
The effect of the phenyl group is to make 
reduction more favorable: compare 3a (£! = 
-0.60 V), mepacrine·H+(£1 = -0.72 V) (Ames et al., I985), and the parent 9-amino 
compound (El = - 0.83 V) (Breyer et al., 
1944). 
Related acridines, which display various 
physiological properties, generally reduce 
at similar potentials. For protonated 
at;nsacrine (m-AMSA) [3, I' -NHS02CH3; 
3 - OCH3], reported reduction potentials 
are - 0.80 V (Anderson ef al., I 984) and 
-0.74V (Crawford et al., I987a). Other 
examples are: the antimalarial mep-
acrine·H+, Ei =- 0.72 V (DMF) (Ames et 
a!., I 985 ); the antibacterial proflavine, 
E! = -0.73 V; and its N-methyl salt, 
El = -0.65 V, both pH 7.3 (Breyer et al., 
1944). Anti-neoplastic drugs with the quin-
olinium nucleus reduced at -0.47 to 
- 1.08 V (Crawford et al., 1987b), and those 
with fused isoquinolinium structures ranged 
from - 0.66 to - 1.10 V (Kovacic et al., 
1986b). 
It is important to note that salt formation 
exerts a favorable influence on both activity 
and ease of reduction. Various findings indi-
~ate a likelihood of aminoacridines function-
~~ in the protonated state (iminium) in vivo 
arhurst & Thomas, I975). Bioactivity is 
Proportional to the percent ionization i~lbert, 1985). Intercalation with DNA is 
ought to be of great significance in the 
+ 
NHR 
Xx 
H 
4 
mechanism of action. Nuclear protonation 
was associated with maximum activity for 
m-AMSA, which was attributed to facili-
tation of site binding (Wilson et al., 1981). 
The 9-amino group enhances basicity 
because of cation delocalization. On the 
other hand, it exerts a pronounced deleteri-
ous influence on reduction potential via the 
same delocalization, illustrated in 4. Thus, 
at pH 5.5, E! for acridine is -0.16 V and for 
the 9-amino derivative, - 0.83 V (Breyer et 
al., 1944). An appreciable body of evidence 
points to steric inhibition of resonance as a 
consequence of-drug binding, which would 
facilitate ET (Ames et al., 1985). Apparently, 
binding to DNA entails intercalation of the 
nucleus with the anilino ring residing in the 
minor groove (Baguley et al., 1981). X-ray 
analyses show the side chain at a consider-
able angle to the acridinium moiety, which 
appears to be a feature of the molecule 
rather than crystal-packing requirements. 
If ET is a mode of action, there may be 
more than one electroactive site involved 
for most of our compounds. The p-phenyl-
enediamine ring of m-AMSA is metabolized 
in vitro by a hepatic microsomal enzyme 
system producing two oxidation products, 
diimine and iminoquinone (Shoemaker et al., 
1984). Wong et al. (1986a) have demon-
strated similar oxidation to diimine by 
Cu(ll). The intercalated diimine moiety, 
complexed with Cu(l), apparently generates 
oxygen-free radicals in a redox reaCtion 
resulting in DNA scission. It is reasonable 
to suggest that the p-aminophenol-type 
O=O=NR 
5 a, R=H b, R=CH3CO 
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drugs in this study (.3a-f) may similarly be 
oxidized to a quinoneimine 5 with analo-
gous production of superoxide. This con-
cept is supported by a number of lines of . 
evidence from related systems. The diimine 
oxidation product of m-AMSA is hydro-
lyzed to a similar iminoquinone structure 
(Shoemaker et al., 1984) which exhibits a 
100-fold greater toxicity to L1210 cells than 
m-AMSA. The toxicity of p-am1nophenol 
(Calder et al., 1979) and acetaminophen 
(Fischer et al., 1985) are believed to involve 
derived quinoneirnines (Sa and Sb, respect-
ively). DNA cleavage has been observed 
with the related 5-iminodaunorubicin 
Cl 
6 
(E! = - 0.46 V) (Lown et al., 1982). It is 
conceivable that the anti-malarial agent 
amodiaquine, 6, operates by such a dual 
mechanism [iminium and iminoquinone] 
(Ames et al., 1985). 
Possibly, .3d also acts as an alkylating 
agent similar to the nitrogen mustards. 
Alkylating species have been postulated as 
precursors for ET (Kovacic. et al., 1986a, b. 
Both ET sites may then act in concert to 
increase the potency. 
Preliminary findings suggested a rela-
tionship between DNA binding and anti-
neoplastic ability. However, this factor 
(intercalation) alone does not explain the 
differences in activity observed for these 
agents (Ralph et al., 1983). m-AMSA and its 
derivatives have been shown to induce 
DNA strand breaks (Ralph et al., 1983), 
which is commonly associated with genera-
tion of oxy radicals (Docampo & Moreno, 
1984; Demopoulos et al., 1980). NAD· re-
duces m-AMSA + to the radical species m-
AMSA · that is able to convert oxygen to 
superoxide (Anderson et al., 1984). DNA-
proflavine complexes form hydroxyl radi-
cals upon irradiation (Piette et al., 1982). 
Structurally related phenazine in quat salt 
form was observed as an electron mediator 
in the production of superoxide (Kulkarni & 
Hodgson, 1980); E' 0 is + 0.08 V (Albert 
1968). There have been photo studies 
demonstrating ET between aminoacridines 
and DNA (Kittler et al., 1980). Also, ET has 
been postulated to aid in the binding of 
aminoacridines to DNA (Atwell et al., 
1984). N-Methylphenanthridinium salts 
also undergo ET (Parkanyi & Leu, 1975). It 
has been proposed that virtually all of the 
clinical and experimental anti-tumor agents 
act via disruption of nucleic acid metabolism 
at some level (Montgomery, 1979). Alterna-
tively, interference with normal ET or with 
the action of DNA topoisomerase II (Ralph 
et al., 1983; Wong et al., 1986b) may be 
involved. m-AMSA stimulates the forma-
tion of DNA-topoisomerase II complexes 
which may lead to strand breakage. The 
cytotoxic effects might be due to interac-
tions with thiol proteins essential for nor-
mal cell function (Wong et al., . 1986b). 
In some cases entailing other anti-neo-
plastic agents, antimetabolites are clearly 
involved, e.g. methotrexate (MTX) (Cole, 
1970) and a-difluoromethylornithine 
(DMFO) (Metcalf et al., 1978). There are 
recent indications that entities are gener-
ated as a result of enzyme binding, which 
display the · potential for ET (Kovacic et aL 
1986b). For example, with MTX, iminium is 
formed as a result of protonation by an 
aspartic acid residue from dihydrofolate 
reductase (Howell et al., 1986 ). The favor-
able reduction potential (Ei = - 0.044-
0.0675 pH, .aqueous buffer) (Gurira ~ 
Bowers, 1983) of the resulting cation 
creates the possibility of participation in 
electrophysiological reactions. SimilarlY 
DFMO is known to combine with the pyri-
doxal moiety of ornithine decarboxylase 
(Metcalf et al., 1978). In the process, conju· 
gated imine is generated which can act as a 
precursor of iminium or a metal compleX· 
Again, ET appears plausible. A recent fasci· 
nating finding involves application of t~e 
same principle to the P-lactam area (KovaciC 
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et al., 1987). The well-documented inhibi-
tion of bacterial cell wall enzyme is gener-
ally thought to be the sole event respon-
sible for activity. It is remarkable that 
lactam ring opening. can lead to an imine 
forerunner of conjugated iminium. Model 
compounds containing these functionalities 
(iminium with attached carboxy)) demon-
strated quite favorable reduction potentials 
(- 0.39 to - 0.61, pH 3.7 to 5 .3). ET could 
result in lethal disruption of normal electron 
transport chains. 
Other considerations 
According to the theory, the different 
agents ad in vivo as ET entities. Reports 
indicate that reduction potential in vivo may 
well be better than in vitro (Barton et al., 
1986; Ames et al., 1986c). These aspects are 
treated in more detail elsewhere (Ames et 
al., 1986b; Crawford et al., 1986a). 
Is it reasonable to expect that the electro-
chemical characteristics of the drugs could 
translate into physiological activity? Prior 
reports indicate such a relationship; e.g., 
Hodnett et al. (1978) were able to identify 
the anti-tumor activity of 75% of the inves-
tigated iminobenzoquinones correctly 
based only on their reduction potentials. 
Anhbacterial mitomycins possessing less 
ne~a~ive E1 values exhibit more powerful 
achvtty (Kinoshita et a/., 1971). A study of 
9-methylaminoacridines revealed a symba-
tic relationship between electrochemical 
properties and antibacterial activity (Shapo-
valov et al., 1980). Correlations have been 
drawn between toxicity and reduction 
potential for a number of aromatic and 
heterocyclic nitro compounds (Chignell, 
1985), including radiosensitizers. 
. The present theory is clearly an over-
~hplification of a very complex situation. 
f ere is important involvement of other 
~ctors, primarily inhibition of DNA syntne-
:~s, DNA defect repair, antimetabolite ac-
lon, and immunological responses (Kovacic 
et al., 1986b). An example of a drug that is 
~at readily accommodated by our approach 
IS 5-fluorouracil (Will & Dolnick, 1986). It is 
conceivable that several mechanisms oper-
ate in concert for certain drugs. 
To summarize, based on the evidence 
from our work and prior contributions, the 
various agents appear to fit the working 
hypothesis: binding (intercalation) to DNA, 
involvement in ET, and production of activ-
ated oxygen. However, in certain cases 
there are gaps that require filling. 
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